-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731.O2.6 731. Autologous Transplantation: Clinical and Epidemiological: Multiple Myeloma and CHIP

Symposia: Autologous Transplantation: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, adult, autoimmune disorders, AML, Biological therapies, Acute Myeloid Malignancies, Hodgkin lymphoma, epidemiology, Non-Biological therapies, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, Translational Research, CHIP, Clinical Research, Chemotherapy, Plasma Cell Disorders, Combination therapy, health outcomes research, Diseases, Immune Disorders, real-world evidence, Therapies, therapy sequence, Lymphoid Malignancies, Adverse Events, Myeloid Malignancies, Biological Processes, survivorship, Study Population, Human, Minimal Residual Disease , Transplantation
Saturday, December 10, 2022: 9:30 AM-11:00 AM
278-282 (Ernest N. Morial Convention Center)
Moderators:
Aimaz Afrough, MD, University of Texas Southwestern and Salomon Manier, MD, PhD, Hopital Huriez Chu Lille
Disclosures:
Manier: AbbVie, Adaptive Biotechnology, Amgen, Celgene/BMS, GlaxoSmithKline, Janssen, Novartis, Oncopeptide, Regeneron, Roche, Takeda: Consultancy.
9:30 AM

Oren Pasvolsky, MD1,2,3*, Denái R Milton, MS4*, Mikael Rauf1*, Sassine Ghanem, MD1,5*, Adeel Masood1*, Ali H Mohamedi1*, Mark R Tanner, PhD1*, Qaiser Bashir, MD1, Samer A Srour, MD, MS1, Neeraj Saini, MD1, Paul Lin, MD, PhD1, Jeremy L. Ramdial, MD1, Yago Nieto, MD1, Guilin Tang, MD, PhD6*, Hans C. Lee, MD7, Krina Patel, MD, MSc7, Partow Kebriaei, MD1, Sheeba K Thomas, MD7, Donna M. Weber, MD7, Robert Z. Orlowski, MD, PhD8, Katy Rezvani, MD1, Elizabeth J Shpall, MD1, Richard E Champlin, MD1, Pei Lin, MD, DM, MDPC6 and Muzaffar H Qazilbash, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Medicine, Alpert Medical School of Brown University, Providence, RI
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

9:45 AM

Christian Straka, M.D.1, Kerstin Schaefer-Eckart, M.D.2, Bernd Hertenstein, MD3*, Florian Bassermann4*, Hans Salwender, M.D.5*, Christian Langer, M.D.6*, Jan Krönke7*, Miriam Kull, MD8*, Georgia Schilling, M.D.9*, Aneta Schieferdecker, M.D.10*, Monika Engelhardt, M.D.11, Stefan Knop, M.D.12*, Julia Reusch, M.D.13*, Wolf Roesler, M.D.14*, Bernd Metzner, M.D.15, Holger Hebart, M.D.16, Albrecht Reichle, M.D.17*, Matthias Grube, M.D.17*, Norbert Frickhofen, M.D.18, Christian Gerecke, M.D.19*, Stephan Fuhrmann, M.D.20*, Wolfram Jung, M.D.21*, Martin Gramatzki, M.D.22, Thomas Decker, M.D.23*, Tobias Dechow, M.D.23*, Jochen Greiner, M.D.24*, Tim H. Brümmendorf, MD25, Juliana Ababei, M.D.26*, Ivana von Metzler, MD27*, Ralph Naumann, MD28, Elisabeth Fritz, M.D.29*, Marcus Hentrich, M.D.30*, Peter Bojko, M.D.30*, Thomas Kubin, M.D.31*, Christian Schmidt, M.D.32*, Martin Kaufmann, MD33, Burkhard Schmidt, M.D.34*, Axel Hinke, Ph.D.35* and Hermann Einsele, MD36

1Clinic of Hematology, Oncology and Stem Cell Transplantation, Muenchen Klinik Schwabing, Munich, Germany
2Klinikum Nuernberg, Nuernberg, Germany
3Klinikum Bremen Mitte, Bremen, Germany
4Department of Medicine III, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany
5Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany
6Kempten Clinic, Kempten, Germany
7Ulm University Hospital, Ulm, Germany
8Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
9UKE, Hamburg, Germany
10University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11Department of Medicine I Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
12University Clinic Würzburg, Wuerzburg, Germany
13Muenster University Hospital, Muenster, Germany
14Med. Klinik III / Poliklinik, Universitätsklinik Erlangen, Erlangen, Germany
15Klinikum Oldenburg, Oldenburg, Germany
16Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany
17University Hospital Regensburg, Regensburg, Germany
18HSK Wiesbaden, Wiesbaden, Germany
19Helios Hospital Berlin Buch, Berlin, Germany
20Helios Klinikum Berlin-Buch, Berlin, Germany
21Universitätsklinikum Göttingen, Göttingen, Germany
22University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
23Onkologie Ravensburg, Ravensburg, Germany
24Diakonie Hospital Stuttgart, Stuttgart, Germany
25Uniklinik RWTH Aachen, Aachen, Germany
26Klinikum Landshut, Landshut, Germany
27University Hospital Frankfurt, Frankfurt, Germany
28Department for Internal Medicine 3, St. Marien-Krankenhaus Siegen, Siegen, Germany
29Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
30Red Cross Hospital Munich, Munich, Germany
31Klinikum Traunstein, Kliniken Südostbayern, Traunstein, Germany
32University Greifswald, Greifswald, Germany
33Medical Centre, Robert-Bosch-Hospital,, Stuttgart, Germany
34Hämatologisch-Onkologische Gemeinschaftspraxis Pasing, Munich, Germany
35CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany
36Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany

10:00 AM

Julie Cote, MD1, Richard Leblanc, MD, FRCPC2, Michael P. Chu3*, Arleigh McCurdy, MD, BSc4, Esther Masih-Khan5,6*, Moustafa Kardjadj, PhD7*, Victor H Jimenez-Zepeda8*, Kevin Song, MD, FRCPC9, Martha L Louzada, MD, MSc10, Hira S Mian, MD, MSc11, Darrell White, MD12*, Michael Sebag, MD, PhD13, Anthony Reiman, MD14*, Julie Stakiw, MD, FRCPC15, Rami Kotb, MD, FRCPC16, Debra Bergstrom17*, Muhammad Aslam, MD18*, Rayan Kaedbey, MD19, Christopher P. Venner, MD20, Engin Gul, BSc, MBA21* and Donna E. Reece, MD, FRCPC22

1Hôpital de l'Enfant-Jésus, Division of Hematology and Medical Oncology, CHU de Québec - Université Laval, Quebec, QC, Canada
2Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
3Department of Oncology, Cross Cancer Institute, Edmonton, Alberta, Edmonton, AB, Canada
4Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
5Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
6Canadian Myeloma Research Group, Vaughan, Ontario, Canada, Vaughan, ON, Canada
7Canadian Myeloma Research Group, Toronto, ON, Canada
8Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada, Calgary, AB, Canada
9Division of Hematology, University of British Columbia and Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
10University of Western Ontario, London Health Sciences Centre, London, ON, Canada
11Juravinski Cancer Centre (Hamilton-CCO), Hamilton, ON, Canada
12Division of Hematology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
13Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
14Oncology, Saint John Regional Hospital, Saint John, NB, CAN
15Saskatoon Cancer Centre, Saskatoon, SK, Canada
16Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
17Division of Hematology, Memorial University of Newfoundland, St John’s, Newfoundland and Labrador, Canada, St John's, NF, Canada
18Allan Blair Cancer Center, Regina, SK, Canada
19Jewish General Hospital, McGill University, Montreal, QC, Canada
20Lymphoma and Myeloma Program, BC Cancer, Vancouver Centre, Vancouver, BC, Canada
21Canadian Myeloma Research Group (CMRG), Concord, ON, Canada
22Princess Margaret Cancer Centre, Toronto, ON, Canada

10:15 AM

Maria-Victoria Mateos, MD1, Joaquín Martínez-López, MD, PhD2*, Paula Rodríguez-Otero, MD, PhD3*, Jesús San-Miguel, MD, PhD4, Veronica Gonzalez-Calle, MD, PhD1*, Marta Sonia Gonzalez, MD5*, Albert Oriol, MD6*, Norma C. Gutierrez1*, Rafael Rios, MD, PhD7*, Laura Rosinol Dachs8*, Miguel Angel Alvarez, MD9*, Joan Bargay, MD, PhD10*, Ana Pilar Gonzalez, PhD11*, Fernando Escalante, MD12*, Adrian Alegre, MD, PhD13, Belén Iñigo, MD14*, Javier de la Rubia, MD15*, Ana Isabel Teruel, MD16*, Felipe De Arriba, PhD17*, Luis Palomera, MD, PhD18*, Miguel-Teodoro Hernández, MD, PhD19*, Javier Lopez Jimenez, MD, PhD20*, Marta Reinoso Segura21*, Aránzazu García Mateo, PhD22*, Enrique M. Ocio1, Joan Bladé, MD, PhD8*, Juan-José Lahuerta, MD, PhD23*, María Teresa Cedena, MD, PhD24*, Noemi Puig, MD, PhD25 and Bruno Paiva26*

1Hospital Universitario de Salamanca,Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
2Department of Hematology, Hospital Universitario 12 de Octubre; Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre i+12,H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain
3Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain
4Clínica Universidad de Navarra, CCUN, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain
5Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, Spain
6Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
7Hospital Universitario Virgen de las Nieves de Granada, Instituto de Investigación Biosanitaria IBS GRANADA, Granada, Spain
8Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
9Hospital Universitario Reina Sofia, Cordoba, Spain
10Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
11Hospital Central de Asturias, Oviedo, Spain
12Hematology Department, Hospital Universitario de León, León, Spain
13Univeritary Hospital La Princesa, Madrid, Madrid, Spain
14Hematology, Hospital Universitario Clínico San Carlos, Madrid, Spain
15Hematology Department, University Hospital La Fe, Valencia, Spain
16Hospital Clínico Universitario de Valencia, VALENCIA, ESP
17Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
18Hospital Clínico U. "Lozano Blesa". Instituto Investigación Sanitaria Aragón, Zaragoza, Spain
19Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain
20Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
21Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
22Hospital General de Segovia, Segovia, Spain
23Hospital Universitario 12 de Octubre; Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre i+12,H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain
24Hospital Universitario 12 de Octubre, CNIO, Madrid, Spain
25Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
26Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain

10:30 AM

Smita Bhatia, MD, MPH1, Chengcheng Yan, MD2*, Melissa A Richard, PhD3*, Jianbo He, MD4, Alysia Bosworth, BA5*, David Crossman6*, Purnima Singh, PhD, MSc7, Lindsey Hageman, MPH1*, Saro H. Armenian, DO, MPH8, Julie M. Vose, MD, MBA9, Daniel J. Weisdorf, MD10, Yutaka Yasui, PhD11*, Benjamin L. Ebert, MD, PhD12, Christopher J. Gibson, MD13, Stephen J Forman, MD14 and Ravi Bhatia, MD15,16

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2University of Alabama at Birmingham, Birmingham, AL
3The University of Texas Health Science Center at Houston, Houston, TX
4Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
5Department of Population Sciences, City of Hope, Durate, CA
6Genomics Core Facility, University of Alabama at Birmingham, Birmingham, AL
7Children's of Alabama Hospital, Birmingham, AL
8Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA
9Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center - Fred and Pamela Buffett Cancer Center, Omaha, NE
10Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
11Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
12Dana-Farber Cancer Institute, Boston, MA
13Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
14Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
15Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
16Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham

10:45 AM

Hussein Awada1*, Carmelo Gurnari, MD1,2, Valeria Visconte, PhD1, Teodora Kuzmanovic, BA1*, Hassan Awada, MD3*, James R. Cook, MD, PhD4, David S. Bosler, MD4*, Brian J. Bolwell, MD5, Ronald M. Sobecks, MD5, Matt Kalaycio, MD5 and Jaroslaw P. Maciejewski, MD, PhD, FACP1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
3Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH
5Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

*signifies non-member of ASH